HYLAN G-F20

N/A

Report date: 2024/11/04 16:56:51

Base Information

Drug NameHYLAN G-F20
Drug Alias NameHylan G-F 20SynviscSynvisc-OneSynvisc DispoSynvisc/Synvisc one +[6] 
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritis
Global Approved IndicationsOsteoarthritis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2007/06/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesGenzyme BiosurgeryPpd Pharmaceutical Development (Beijing) Co Ltd
Active IndicationsOsteoarthritis
Inactive IndicationsOsteoarthritis, Knee

Other Information

ATC CodeM05
Related LinksN/A